Packaging & Product Protection Featured Articles

  1. What Does “Child Resistant Packaging” Mean In Pharma?

    Understand which products need child resistant packaging how can manufacturers ensure they are up to standards.

  2. Pharmaceutical Primary Packaging Strategies

    Packaging and presentation is crucial to study success. Drug stability, regulatory strategy, and patient-centered design are just some of the factors to consider. Explore the best packaging strategies to achieve longer stability and adherence.

  3. With Serialization Mandate Looming, Is Your Data Management System Ready?

    The next phase of the Drug Supply Chain Security Act (DSCSA) is approaching, and it is approaching quickly. This is an especially crucial year as manufacturers face the November deadline that requires packages to be marked with a product identifier, serial number, lot number, and expiration. From there, the remaining deadlines for other stakeholders in the life sciences supply chain are staggered throughout the remaining six years of the regulation’s 10-year plan. By 2023, the goal is to have achieved item-level traceability from end to end that will allow detection and/or tracking of suspicious or dangerous products in the pharma supply chain.

  4. Simulation Software Enhances Packaging Line Design

    Modeling tool helps companies right size equipment for efficiency and savings.

  5. Flexible Mobile Biocontainment Units Prevent Spread Of Transmissible Diseases

    There exists two key methods for controlling serious outbreaks of transmissible diseases: therapeutic countermeasures and transmission control through isolation and containment.

  6. The Impact Of Serialization Requirements On Packaging Operations

    The November 2017 deadline for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target.

  7. Advancing Clinical Study Execution And Expediting Clinical Supplies

    The shift toward biologics, globalization of clinical trials, and regulatory and commercial pressures has placed new stresses on clinical supply chains.

  8. A Bridge Over Troubled Water: The Journey To Serialization Compliance

    This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with preparation for each phase accumulating into a potentially high overall price tag.

  9. Blister Package Integrity Testing Using Non-Destructive Methods

    Dye ingress leak testing and vacuum decay are the most common methods used for leak testing blister packages.

  10. The Role Contract Manufacturers Play In Pharmaceutical Manufacturing And Packaging

    The pharmaceutical industry is changing at a rapid pace with a lot of trends and business relationships. This not only involves new medical developments, guidelines and corresponding equipment, but also the roles of all stakeholders. Uwe Harbauer, Senior Vice President of Bosch Packaging Technology’s Pharma Business Unit, shares his thoughts about the pharma marketing and relationships today.